The Oxford Vaccine Group, led by Prof Andrew Pollard, is renowned for collaborating with Oxford’s Jenner Institute in ...

Pliant Therapeutics paused its phase 2b/3 trial of bexotegrast for idiopathic pulmonary fibrosis due to DSMB recommendations.

Feb. 5, 2025 — Researchers report that all nine patients in a clinical trial being treated for stage III or IV clear cell renal cell carcinoma (a form of kidney cancer), generated a successful ...

COVID Vaccines Linked to Autoimmune Disease** In a groundbreaking development, recent research has unveiled that COVID-19 vaccines may act as a trigger for ...

The trial will evaluate the safety and effectiveness of a next-generation vaccine administered through a nasal spray or ...

The narrative is false that the COVID vaccine was rushed and not properly tested. It and other vaccines are safe and ...

Investing.com -- AIM ImmunoTech (NYSE: AIM) Inc. (NYSE American: AIM) has announced its intention to develop Ampligen as a vaccine adjuvant for avian influenza. This move is part of AIM's antiviral ...

A number of High Street chemists and private clinics sell and administer the Pfizer Covid vaccine directly to the public. The ...

AstraZeneca’s Imfinzi (durvalumab) has received a positive recommendation from the European Medicines Agency’s Committee for Medicinal Produc ...

Pharmaceutical giant AstraZeneca has axed plans to invest £450m in expanding its vaccine manufacturing warehouse in Speke, ...

Imfinzi recommended for approval in the EU by CHMP as first and only immunotherapy for limited-stage small cell lung cancer Recommendation based on ADRIATIC Phase III trial results which ...

They will be followed by vaccine safety experts Professor Dani Prieto ... global product lead at AstraZeneca. Public hearings for module four of the Covid-19 Inquiry will run until January 31.